scispace - formally typeset
Y

Yosef Shiloh

Researcher at Tel Aviv University

Publications -  206
Citations -  35738

Yosef Shiloh is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Ataxia-telangiectasia & DNA damage. The author has an hindex of 75, co-authored 200 publications receiving 34100 citations. Previous affiliations of Yosef Shiloh include German Cancer Research Center & Weizmann Institute of Science.

Papers
More filters
Journal Article

Rapamycin resistance in ataxia-telangiectasia.

TL;DR: 3 A-T cell lines are more resistant than control cells to rapamycin's growth inhibiting effects but were more sensitive to the PI3-kinase inhibitor wortmannin, demonstrating that the ATM protein is not a direct target for rapamyzin but its functional loss renders cells more resistant to this compound.
Journal ArticleDOI

Novel DNA sequences at chromosome 10q26 are amplified in human gastric carcinoma cell lines: molecular cloning by competitive DNA reassociation

TL;DR: The cloned sequences supply a starting point for identification of novel genes which might be involved in the pathogenesis of gastric cancers, and are located in a relatively unexplored domain of the human genome.
Journal ArticleDOI

In search of drug treatment for genetic defects in the DNA damage response: the example of ataxia-telangiectasia.

TL;DR: A high throughput strategy for drug screening for A-T that is based on a certain redundancy among ATM and related proteins gives hope that activation of ATM-redundant activities might form a basis for drug treatment of A- T.
Journal ArticleDOI

Astrocyte Dysfunction Associated with Cerebellar Attrition in a Nijmegen Breakage Syndrome Animal Model

TL;DR: It is shown that conditional inactivation of the murine Nbs1 gene has a profound effect on the integrity and the functionality of the glial cells, which suggests their crucial role in the pathogenesis of NBS.
Journal ArticleDOI

Malfunctioning DNA Damage Response (DDR) Leads to the Degeneration of Nigro-Striatal Pathway in Mouse Brain

TL;DR: The results indicate that malfunctioning DNA damage response severely affects the integrity of the nigro-striatal pathway and suggest a new neurodegenerative pathway in Parkinsonian syndromes.